TECHWIRE 30
(CIX: WRAL30)  1,076.65    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: Apple)  104.83    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: QUINTILES)  56.99    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(OP: BASF SE)  89.65    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: BioCryst)  12.19    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: BioDelivery)  16.38    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: CEMP)  12.32    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: Cisco Systems)  23.57    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: Cree)  29.40    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: DARA)  0.90    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: EMC CORPORATION)  27.70    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(NQ: Extreme Networks)  3.12    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: FB)  80.04    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: GLAXOSMITHKLINE)  45.36    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(NQ: GOOG)  543.98    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: IBM)  162.18    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(NY: LH)  102.68    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(OP: Lenovo Group)  29.02    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: MRK)  56.63    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(NQ: Microsoft Corp)  45.02    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: NTAP)  40.30    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: NOVARTIS AG)  89.24    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(OP: Novozymes A/S)  44.54    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: PFIZER)  28.60    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(NQ: Pozen)  8.75    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NY: RED HAT)  55.51    (0 %)  Updated: 06:40 PM EDT, Oct 23 2014
(NQ: BBRY)  10.31    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: Salix)  135.56    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014
(NQ: SQI)  15.52    (0 %)  Updated: 08:10 PM EDT, Oct 23 2014

Posts tagged “N.C. Biotech Center”

2:28 p.m. Tuesday

NC Biotech Center awards $885,000 in grants, loans across state

Biotech During the same period, the Center determined that more than $13 million in outside funding was raised by companies previously awarded NCBiotech loans.

6:59 a.m. Monday

Have news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

October 15

AskBio, spinouts tackle big diseases with nano technology

AskBio founder R. Jude Samulski, Ph.D. Hemophilia. Duchenne muscular dystrophy. Epilepsy. Alzheimer's disease. Diabetic retinopathy. Age-related macular degeneration. Osteoarthritis. These are just some of the diseases that Chapel Hill-based Asklepios BioPharmaceutical (AskBio) is working to alleviate through the development and delivery of novel, intracellular protein therapeutics using its cutting-edge Biological Nano Particle (BNP) technology.

October 14

Bioterror threat: 'If I want to attack somebody nowadays, all I need is a plane ticket to an international destination'

Bioterror  At the first "Bio Defense Summit, leaders from across North Carolina discuss the threats of bioterror and how N.C. can secure more federal research and development funds to help head off any future attack on the U.S. The Ebola epidemic has only increased concerns about what a bioterror attack could mean.

Updated October 13

Making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

October 6

Making some news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

October 3

Durham drug firm Argos to add 230 jobs, gets $9.5M in incentives

One of North Carolina's most high-profile homegrown life science companies, Argos Therapeutics, is about to build a 100,000-square-foot state-of-the-art biomanufacturing facility in the Research Triangle Park.

Architect's rendering shows planned 100,000-square-foot Argos biomanufacturing facility in RTP. Architect's rendering shows planned 100,000-square-foot Argos biomanufacturing facility in RTP.

October 3

Durham biotech startup Sentilus is sold to Georgia company

Biotech Sentilus, a two-year-old Durham biotech company, has been purchased by a Georgia blood testing company run by the son of a former Durham mayor.

Updated September 24

Novartis dedicates $1B vaccine plant with VIP flu shots as NC exec who recruited the firm will watch

It's probably a safe bet that Gov. Pat McCrory has already received his flu shot for the 2014-5 season, but he and other VIPs can line up for vaccinations today as Novartis formally dedicates production at its mammoth $1 billion plant in Holly Springs. But there's also an interesting back story to the event: The N.C. Biotechnology Center exec who helped recruit Novartis to N.C. way back in 2006.

Novartis plant in Holly Springs Novartis plant in Holly Springs

September 22

Premium Lock Have news? Views? Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

September 12

Premium Lock FDA grants 'orphan' drug status to Viamet fungus fighter

Viamet Durham's Viamet Pharmaceuticals has been granted an orphan drug designation by the U.S. Food & Drug Administration for one of its lead drug candidates, an oral antifungal agent code-named VT-1129.

September 11

Premium Lock Agriculture, biotech leaders to gather at NCSU for food 'summit'

AgBiotech Summit Food and agricultural experts from around the nation will join North Carolina peers at the McKimmon Conference Center in Raleigh Nov. 18 and 19 for a wide-ranging discussion of technologies and policies affecting food production.

September 10

Premium Lock Liquidia's spin-out cycle 2: Another new venture is born

Liquidia, itself spun out of the University of North Carolina at Chapel Hill in 2004 by superstar scientists Joe DeSimone and Ed Samulski, has "re-spun" its second new pharmaceutical company, this one to specifically target yet-undisclosed "oral health conditions."

The PRINT platform The PRINT platform

September 9

Premium Lock As Bayer CropScience breaks ground for $30M greenhouse, there's more growth to come

Jim Blome heads one of the world's largest seed companies, but he isn't ready to spill the beans on Bayer CropScience's future plans for expansion on its Research Triangle Park campus.

Rendering of Bayer CropScience's new RTP greenhouse Rendering of Bayer CropScience's new RTP greenhouse

September 8

Premium Lock We want your news: Send company updates to WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

September 5

Premium Lock How to win grants: The 4 commandments for proposals

Research Grant It's no secret that research careers can thrive or die on grant funding. That's why it's always surprising to find bright people with advanced levels of education who just don't know how to make "the ask." Here is advice on how to win at writing grants.

Updated September 2

Premium Lock Dignify Therapeutics wins SBIR grant, aims for $3M in funding

Dignify Therapeutics The drug development company focused on restoring bladder and bowel control to people with spinal injuries has been awarded $159,000 Small Business Innovation Research (SBIR) grant as global market potential for their flagship product continues to grow.

September 2

Premium Lock Your company making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRAL TechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 22

Premium Lock Exclusive: New Biotech Center CEO will 'push the envelope with new ideas and programs'

In the second part of an exclusive in-depth Q&A with Doug Edgeton, the new CEO of the North Carolina Biotechnology Center, the veteran life science executive talks about his goals, his background, and the Center's commitment to development of the sector across the state.

Douge Edgeton  Douge Edgeton

August 22

Premium Lock Exclusive: New Biotech Center CEO lays out future vision

Life science veteran executive Doug Edgeton, who once ran the Piedmont Research Park in Winston-Salem, spells out his vision for where he hopes to take the North Carolina Biotechnology Center as its new CEO in an exclusive Q&A with WRAL Tech Wire. He says N.C. has a fight on its hands to grow one of the nation's largest biotech industry clusters. But Edgeton believes he's ready for the job. Restoring state budget cuts is a "top priority" as well as recruiting and helping build new businesses. "We have to be creative in finding ways to bring technologies to the marketplace that will improve lives, create well-paying jobs and create wealth for the people of our state," Edgeton explains.

Doug Edgeton Doug Edgeton

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll